ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - clomipramine hydrochloride, quantity: 25 mg - tablet, film coated - excipient ingredients: purified talc; maize starch; lactose monohydrate; sodium starch glycollate; magnesium stearate; povidone; titanium dioxide; hypromellose; macrogol 400 - for the treatment o f major depression; obsessive-compulsive disorders and phobias in adults; and cataplexy associated with narcolepsy.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - tramadol hydrochloride, quantity: 300 mg - tablet, modified release - excipient ingredients: povidone; polyvinyl acetate; colloidal anhydrous silica; hydrogenated vegetable oil; xanthan gum; hydroxypropyl distarch phosphate; magnesium stearate; sodium lauryl sulfate - indicated for the management of severe pain where: ? other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and ? the pain is opioid-responsive, and ? requires daily, continuous, long-term treatment. not indicated for use in chronic non-cancer pain other than in exceptional circumstances. not indicated as an as-needed (prn) analgesia.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - tramadol hydrochloride, quantity: 200 mg - tablet, modified release - excipient ingredients: hydrogenated vegetable oil; povidone; hydroxypropyl distarch phosphate; sodium lauryl sulfate; xanthan gum; magnesium stearate; polyvinyl acetate; colloidal anhydrous silica - indicated for the management of severe pain where: ? other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and ? the pain is opioid-responsive, and ? requires daily, continuous, long-term treatment. not indicated for use in chronic non-cancer pain other than in exceptional circumstances. not indicated as an as-needed (prn) analgesia.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - tramadol hydrochloride, quantity: 100 mg - tablet, modified release - excipient ingredients: hydrogenated vegetable oil; sodium lauryl sulfate; colloidal anhydrous silica; hydroxypropyl distarch phosphate; povidone; magnesium stearate; polyvinyl acetate; xanthan gum - indicated for the management of severe pain where: ? other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and ? the pain is opioid-responsive, and ? requires daily, continuous, long-term treatment. not indicated for use in chronic non-cancer pain other than in exceptional circumstances. not indicated as an as-needed (prn) analgesia.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - roxithromycin, quantity: 300 mg - tablet, film coated - excipient ingredients: hyprolose; povidone; propylene glycol; purified talc; sodium starch glycollate type a; hypromellose; sodium starch glycollate type b; maize starch; magnesium stearate; colloidal anhydrous silica; poloxamer; glucose; titanium dioxide - adults: roxithromycin is indicated for the treatment of the following types of mild to moderately severe infections caused by or likely to be caused by susceptible microorganisms: upper respiratory tract infection: acute pharyngitis, tonsillitis and sinusitis. lower respiratory tract infection: acute bronchitis and acute exacerbations of chronic bronchitis; community acquired pneumonia. skin and skin structure infections. nongonococcal urethritis. appropriate culture and sensitivity tests should be performed when necessary to determine organism susceptibility and thus treatment suitability. therapy with roxithromycin may be initiated before results of these tests are known; once results become available, appropriate therapy should be continued.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - sertraline hydrochloride, quantity: 112 mg (equivalent: sertraline, qty 100 mg) - tablet, film coated - excipient ingredients: calcium hydrogen phosphate; microcrystalline cellulose; sodium starch glycollate; hyprolose; magnesium stearate; titanium dioxide; hypromellose; polysorbate 80; iron oxide yellow; macrogol 400 - children and adolescents,sertraline generichealth is indicated for the treatment of children (aged 6 years of age and older) and adolescents with ocd.,adults,sertraline generichealth is indicated for the treatment of major depression, obsessive compulsive disorder (ocd) and panic disorder.,sertraline generichealth is indicated for the treatment of social phobia (social anxiety disorder) and the prevention of its relapse.,sertraline generichealth is indicated for the treatment of premenstrual dysphoric disorder (pmdd) as defined by dsm-iv criteria.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - sertraline hydrochloride, quantity: 56 mg (equivalent: sertraline, qty 50 mg) - tablet, film coated - excipient ingredients: calcium hydrogen phosphate; microcrystalline cellulose; sodium starch glycollate; hyprolose; magnesium stearate; titanium dioxide; hypromellose; polysorbate 80; macrogol 400; indigo carmine aluminium lake - children and adolescents,sertraline generichealth is indicated for the treatment of children (aged 6 years of age and older) and adolescents with ocd.,adults,sertraline generichealth is indicated for the treatment of major depression, obsessive compulsive disorder (ocd) and panic disorder.,sertraline generichealth is indicated for the treatment of social phobia (social anxiety disorder) and the prevention of its relapse.,sertraline generichealth is indicated for the treatment of premenstrual dysphoric disorder (pmdd) as defined by dsm-iv criteria.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - tramadol hydrochloride, quantity: 50 mg - tablet, modified release - excipient ingredients: lactose monohydrate; magnesium stearate; iron oxide yellow; hypromellose; microcrystalline cellulose; titanium dioxide; macrogol 6000; colloidal anhydrous silica; purified talc; propylene glycol - zydol sr is indicated for the management of severe pain where: ? other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and ? the pain is opioid-responsive, and ? requires daily, continuous, long term treatment. zydol sr is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. zydol sr is not indicated as an as-needed (prn) analgesia.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - tramadol hydrochloride, quantity: 50 mg - tablet, modified release - excipient ingredients: purified talc; lactose monohydrate; hypromellose; titanium dioxide; propylene glycol; magnesium stearate; macrogol 6000; colloidal anhydrous silica; iron oxide yellow; microcrystalline cellulose - tramal sr is indicated for the management of severe pain where: ? other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and ? the pain is opioid-responsive, and ? requires daily, continuous, long term treatment. tramal sr is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. tramal sr is not indicated as an as-needed (prn) analgesia.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - paroxetine hydrochloride, quantity: 22.22 mg (equivalent: paroxetine, qty 20 mg) - tablet, film coated - excipient ingredients: sodium starch glycollate; magnesium stearate; microcrystalline cellulose; mannitol; basic butylated methacrylate copolymer; titanium dioxide; purified talc; polyvinyl alcohol; sodium lauryl sulfate; glyceryl monostearate - treatment of major depression and for the prevention of relapse of depressive symptoms; treatment of obsessive compulsive disorder and for the prevention of relapse of ocd; treatment of panic disorder and for the prevention of relapse of panic disorder; treatment of social anxiety disorder/ social phobia; treatment of generalised anxiety disorder; and treatment of post-traumatic stress disorder